Trombofilie a trombóza
- MUDr. Jaromír Gumulec, Ústav klinické hematologie FN Ostrava
- MUDr. Alena Buliková, Oddělení klinické hematologie FN Brno, Brno
Comparison of the efficacy and safety of new oral anticoagulants with warfarin in patients with atrial fibrillation: a meta-analysis of randomised trials
Otevřít | 2014 | MUDr. Libor Červinek
Heparin thromboprophylaxis in medical-surgical critically ill patients: a systematic review and meta-analysis of randomized trials
Otevřít | 2013 | MUDr. František Folber
Guidelines on oral anticoagulation with warfarin - fourth edition
Otevřít | 2011 | MUDr. Jana Gombošová
Perioperative management of patients who are receiving warfarin therapy: an evidence-based and practical approach
Otevřít | 2011 | MUDr. Marie Tichá
Guidelines on travel-related venous thrombosis
Otevřít | 2010 | MUDr. Jana Gombošová
Apixaban versus enoxaparin for thromboprophylaxis after knee replacement (ADVANCE-2): a randomised double-blind trial
Otevřít | 2010 | MUDr. Jana Gombošová
Efficacy and safety of dabigatran compared with warfarin at different levels of international normalised ratio control for stroke prevention in atrial fibrillation: an analysis of the RE-LY trial
Otevřít | 2010 | MUDr. Marie Langová
Dabigatran versus warfarin in patients with atrial fibrillation
Otevřít | 2009 | MUDr. Marie Tichá
Dabigatran versus warfarin in the treatment of acute venous tromboembolism
Otevřít | 2009 | MUDr. Marie Tichá
Venous thromboembolism in the hematologic malignancies
Otevřít | 2009 | MUDr. Ondřej Zapletal a MUDr. Jan Blatný, Ph.D.
Dabigatran etexilate versus enoxaparin for prevention of venous thromboembolism after total hip replacement: a randomised, double-blind, non-inferiority trial
Otevřít | 2007 | MUDr. František Folber
International consensus statement on an update of the classification criteria for definite antiphospholipid syndrome (APS)
Otevřít | 2006 | MUDr. Alena Buliková, Ph.D.